INAF suffers loss, capital deficiency rises 42.28%
29 Apr 2025 16:18
INAF's revenue fell, mainly from ethical sales.
Wage arrears rise, INAF reveals divestment progress
14 Mar 2025 11:00
INAF is selling assets to settle employee wages of IDR 98.93 billion. Is the asset value sufficient?
Employee's wages in arrears, Indofarma to divest assets
03 Sep 2024 09:07
PT Indofarma Tbk (INAF), a state-owned medicine and medical device manufacturer, is said to sell off its remaining assets to pay arrears to its own employees.
Indofarma still on loss streak until H1 2024
02 Aug 2024 13:01
PT Indofarma Tbk (INAF), a state-owned pharmaceutical company owned through PT Bio Farma (Persero), booked a loss of IDR 101.94 billion in the first half (H1) of 2024.